Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 25.04% |
| Q3 2025 | -10.02% |
| Q2 2025 | 10.46% |
| Q1 2025 | -19.67% |
| Q4 2024 | 34.15% |
| Q3 2024 | 8.44% |
| Q2 2024 | 14.58% |
| Q1 2024 | -12.15% |
| Q4 2023 | 36.72% |
| Q3 2023 | -6.96% |
| Q2 2023 | 7.74% |
| Q1 2023 | -14.73% |
| Q4 2022 | 13.52% |
| Q3 2022 | 3.22% |
| Q2 2022 | -11.34% |
| Q1 2022 | -0.14% |
| Q4 2021 | 17.50% |
| Q3 2021 | -7.77% |
| Q2 2021 | -13.69% |
| Q1 2021 | -21.73% |
| Q4 2020 | 14.17% |
| Q3 2020 | -3.09% |
| Q2 2020 | -6.62% |
| Q1 2020 | 10.53% |
| Q4 2019 | 5.50% |
| Q3 2019 | 1.94% |
| Q2 2019 | 1.88% |
| Q1 2019 | -0.21% |
| Q4 2018 | 2.42% |
| Q3 2018 | 16.79% |
| Q2 2018 | 8.48% |
| Q1 2018 | 8.09% |
| Q4 2017 | 30.10% |
| Q3 2017 | 8.23% |
| Q2 2017 | 8.82% |
| Q1 2017 | -3.62% |
| Q4 2016 | 29.74% |
| Q3 2016 | -6.25% |
| Q2 2016 | 16.67% |
| Q1 2016 | 6.43% |